Urology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gaston RS et al. - This study demonstrates marked variability in the use of cardioprotective medications in kidney transplant recipients, a finding that may reflect, among several possible explanations, clinical uncertainty due the lack of randomized trials for these medications in this population.

Related Articles

The Alphabet Soup of Kidney Transplantation: SCD, DCD, ECD—Fundamentals for the Practicing Nephrologist
Clinical Journal of the American Society of Nephrology, 11/16/09    Relevance Score: 70%

The Evolution of Kidney Function After Lung Transplantation: A Retrospective Cohort Study
Transplantation Proceedings, 11/11/09    Relevance Score: 70%

ABO-Incompatible Kidney Transplantation
Transplantation, 10/29/09    Relevance Score: 70%

Ethical Issues and Living Unrelated Donor Kidney Transplantation
Iranian Journal of Kidney Diseases, 10/13/09    Relevance Score: 69%

The Science of Stewardship: Due Diligence for Kidney Donors and Kidney Function in Living Kidney Donation—Evaluation, Determinants, and Implications for Outcomes
Clinical Journal of the American Society of Nephrology, 10/08/09    Relevance Score: 69%

Today in Transplantation...keeping you current

Arteriovenous fistula in an autotransplanted kidney segment: Successful angiographic management
Scandinavian Journal of Urology and Nephrology, 12/04/09

Indices of systemic atherosclerosis are superior to ultrasound resistance indices for prediction of allograft survival
Nephrology Dialysis Transplantation, 12/04/09

Echocardiographic findings in kidney transplant patients with autosomal dominant polycystic kidney disease
Scandinavian Journal of Urology and Nephrology, 12/04/09